Results 141 to 150 of about 79,696 (205)

Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro [PDF]

, 1994
Forssmann, W. G., Jonas, Udo, Meyer, M. F., Schulz-Knappe, P., Stief, Christian Georg, Taher, A., Truss, Michael C.   +6 more
core   +1 more source

A Review of Combined Phosphodiesterase-5-Inhibitors and α-Blockers versus Phosphodiesterase-5-Inhibitors Alone for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia. [PDF]

Arab J Urol
Jackson EM, Khooblall P, Lundy SD, Bajic P.   +3 more
europepmc   +1 more source

Discovery of trisubstituted pyrazolines as a novel scaffold for the development of selective phosphodiesterase 5 inhibitors. [PDF]

Bioorg Chem, 2020
Abdel-Halim M, Tinsley H, Keeton AB, Weam M, Atta NH, Hammam MA, Hefnawy A, Hartmann RW, Engel M, Piazza GA, Abadi AH.   +10 more
europepmc   +1 more source

Phosphodiesterase-5 Inhibitors and Dementia Risk: A Real-World Study.

Neuroepidemiology
Gronich N, Stein N, Saliba W.
europepmc   +1 more source

The potential therapeutic effect of phosphodiesterase 5 inhibitors in the acute ischemic stroke (AIS). [PDF]

Mol Cell Biochem
AlRuwaili R, Al-Kuraishy HM, Alruwaili M, Khalifa AK, Alexiou A, Papadakis M, Saad HM, Batiha GE.   +7 more
europepmc   +1 more source

Phosphodiesterase Type 5 Inhibitors and COVID-19: Are They Useful In Disease Management?

The World Journal of Men's Health, 2020
Nicola Mondaini
doaj   +1 more source

The first-generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue. [PDF]

Andrology, 2019
Zucchi A, Costantini E, Scroppo FI, Silvani M, Kopa Z, Illiano E, Petrillo MG, Cari L, Nocentini G.   +8 more
europepmc   +1 more source

Demonstration of a Heat-Stable Cyclic GMP Phosphodiesterase in the Medium of Physarum flavicomum [PDF]

, 1985
Lynch, Thomas J., Ross, Mark S.
core   +2 more sources

Notes on Three Palustrine Natural Community Types in the Arkansas Ozarks [PDF]

, 1985
Orzell, Steve L., Pell, William F., Tucker, Gary E.   +2 more
core   +2 more sources